Evidence map›Paper›PMID 21765007›Full record

SynthesisCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2011

Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis.

Yumie Takata, Alan R Kristal, Irena B King, Xiaoling Song, Alan M Diamond, Charles B Foster, Carolyn M Hutter, Li Hsu, David J Duggan, Robert D Langer and 6 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Selenium for preventing cancer.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Selenium in Surgery.Cureus · 2024
    Review
  6. Article
  7. Article
  8. The Role of Selenium in Pathologies: An Updated Review.Antioxidants (Basel, Switzerland) · 2022
    Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Friend or foe? The current epidemiologic evidence on selenium and human cancer risk.Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews · 2013
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Yumie TakataPublic Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA.
Alan R Kristal
Irena B King
Xiaoling Song
Alan M Diamond
Charles B Foster
Carolyn M Hutter
Li Hsu
David J Duggan
Robert D Langer
Helen Petrovitch
James M Shikany
Thomas L Vaughan
Johanna W Lampe
Ross L Prentice
Ulrike Peters
Fred Hutch Cancer Center · USTranslational Genomics Research Institute · USCancer Research Center · USPacific Health Research and Education Institute · USCleveland Clinic · USJackson Memorial Hospital · USUniversity of Alabama at Birmingham · USUniversity of Illinois Chicago · US

Funding

CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042119 · WH · YESHIVA UNIVERSITY · PI WASSERTHEIL-SMOLLER, SYLVIA · 1994 to 2001
$2.2M
Prospective Study on Selenium, Genectics of Selenoenzymes, and Colorectal CancerR01CA120582 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETERS, ULRIKE · 2006 to 2014
$2.1M
VANGUARD CENTER FOR WOMEN'S HEALTH INITIATIVEN01WH032101 · WH · UNIVERSITY OF MINNESOTA TWIN CITIES · PI GRIMM, RICHARD H · 1993 to 2000
$1.7M
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROLK05CA124911 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 2007 to 2016
$1.6M
VANGUARD CENTER FOR WOMEN'S HEALTH INITIATIVEN01WH032111 · WH · EMORY UNIVERSITY · PI WATTS, NELSON · 1993 to 2001
$1.6M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042123 · WH · MEDSTAR RESEARCH INSTITUTE · PI HOWARD, BARBARA V · 1994 to 2000
$1.4M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042109 · WH · STANFORD UNIVERSITY · PI STEFANICK, MARCIA L · 1994 to 2000
$1.4M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042114 · WH · KAISER FOUNDATION RESEARCH INSTITUTE · PI RITENBAUGH, CHERYL K · 1994 to 2000
$1.4M
Colon Cancer Prevention with SeleniumR01CA127943 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DIAMOND, ALAN · 2009 to 2013
$1.4M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042108 · WH · GEORGE WASHINGTON UNIVERSITY · PI HSIA, JUDITH · 1994 to 2000
$1.4M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042124 · WH · RUSH UNIVERSITY MEDICAL CENTER · PI BLACK, HENRY R · 1994 to 2000
$1.4M
CLIN CTR CLIN TRIAL/OBSERVATIONAL STUDY OF WHIN01WH042131 · WH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI O'SULLIVAN, MARY J · 1994 to 2000
$1.3M
NCI NIH HHS K05 CA124911NCI NIH HHS R01 CA120582NCI NIH HHS R01 CA127943NHLBI NIH HHS N01 WH032105NHLBI NIH HHS N01 WH042131WHI NIH HHS N01 WH022110WHI NIH HHS N01 WH024152WHI NIH HHS N01 WH032100WHI NIH HHS N01 WH032101WHI NIH HHS N01 WH032102WHI NIH HHS N01 WH032106WHI NIH HHS N01 WH032108WHI NIH HHS N01 WH032109WHI NIH HHS N01 WH032111WHI NIH HHS N01 WH032112WHI NIH HHS N01 WH032113WHI NIH HHS N01 WH032115WHI NIH HHS N01 WH032118WHI NIH HHS N01 WH032119WHI NIH HHS N01 WH032122WHI NIH HHS N01 WH042107WHI NIH HHS N01 WH042108WHI NIH HHS N01 WH042109WHI NIH HHS N01 WH042110WHI NIH HHS N01 WH042111WHI NIH HHS N01 WH042112WHI NIH HHS N01 WH042113WHI NIH HHS N01 WH042114WHI NIH HHS N01 WH042115WHI NIH HHS N01 WH042116WHI NIH HHS N01 WH042117WHI NIH HHS N01 WH042118WHI NIH HHS N01 WH042119WHI NIH HHS N01 WH042120WHI NIH HHS N01 WH042121WHI NIH HHS N01 WH042122WHI NIH HHS N01 WH042123WHI NIH HHS N01 WH042124WHI NIH HHS N01 WH042125WHI NIH HHS N01 WH042126WHI NIH HHS N01 WH042129WHI NIH HHS N01 WH042130WHI NIH HHS N01 WH042132WHI NIH HHS N01 WH044221
6 · The paper itself

Abstract

backgroundSelenium may prevent colorectal cancer. However, several previous studies are small and few investigated the association between selenium and colorectal cancer among women whose selenium metabolism may differ from men. Furthermore, genetic variants in selenoenzymes may be associated with colorectal cancer risk.

methodsThis nested case-control study investigated whether serum selenium concentration and genetic variants in five selenoenzymes (glutathione peroxidase 1-4 and selenoprotein P) were associated with colorectal cancer risk in 804 colorectal cancer cases and 805 matched controls from the Women's Health Initiative (WHI) Observational Study. A meta-analysis was conducted to compare the WHI result with previous studies including 12 observational studies and two clinical trials on selenium.

resultsWithin the WHI, selenium concentrations were relatively high (mean = 135.6 μg/L) and were not associated with colorectal cancer risk (P(trend) = 0.10); the adjusted OR comparing the fifth with first quintile was 1.26 (95% CI, 0.91-1.73). Moreover, genetic variants in selenoenzymes were not significantly associated with colorectal cancer risk. Consistent with the finding in WHI, our meta-analysis showed no association between selenium and colorectal tumor risk in women (OR = 0.97; 95% CI, 0.79-1.18) comparing the highest quantile with the lowest); however, in men, there was a significant inverse association (OR = 0.68; 95% CI, 0.57-0.82) (P = 0.01).

conclusionConsistent with previous studies, we observed no protective effect of selenium on colorectal cancer among women. IMPACT: Our analyses suggest that a population with relatively high selenium concentrations, especially women, would not benefit from increasing selenium intake.

Indexed as

AgedCase-Control StudiesColorectal NeoplasmsFemaleGenetic Predisposition to DiseaseGlutathione PeroxidaseHumansMaleMiddle AgedRisk FactorsSeleniumSelenoprotein PUnited StatesWomen's HealthGlutathione PeroxidaseSeleniumSelenoprotein P

Identifiers

PMID21765007
PMCPMC3191200
OpenAlexW2158932345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.